Silver-containing dressings

K. Ousey, C. D. Roberts, D. Leaper

Research output: Chapter in Book/Report/Conference proceedingChapter

6 Citations (Scopus)

Abstract

The use of silver as an antibacterial has been known for centuries, but its topical use in antimicrobial dressings to prevent or treat infection in a wide range of acute and chronic wounds is relatively new. Extensive laboratory and clinical evaluations have shown the antibacterial value of silver dressings, although efficacy may be dependent on the properties of a silver dressing, of which there are a wide range available. However, a randomised controlled trial and two Cochrane systematic reviews and meta-analyses have concluded that there is insufficient evidence to show that silver dressings improve healing rates. This conclusion is flawed as silver dressings never were meant to heal wounds, only to facilitate control of bioburden.Topical antiseptics, including silver, are well suited to control of bioburden and biofilm when used in conjunction with adequate debridement, and no relevant microbial resistance has been found. The rise of antibiotic-resistant organisms makes the reintroduction of a wider use of topical antiseptics an attractive alternative when antibiotic stewardship controls inappropriate antibiotic use.Few adequate randomised clinical trials have been undertaken, and supportive laboratory findings do need to be interpreted carefully into clinical practice. Nevertheless, silver dressings have a clear role in the management of bioburden and biofilm in open wounds.

LanguageEnglish
Title of host publicationFunctional Biomaterials
PublisherElsevier Inc.
Pages403-437
Number of pages35
Volume2
ISBN (Electronic)9780081006061
ISBN (Print)9781782424567
DOIs
Publication statusPublished - 1 Jun 2016

Fingerprint

Bandages
Silver
Local Anti-Infective Agents
Biofilms
Anti-Bacterial Agents
Wounds and Injuries
Randomized Controlled Trials
Debridement
Meta-Analysis
Infection

Cite this

Ousey, K., Roberts, C. D., & Leaper, D. (2016). Silver-containing dressings. In Functional Biomaterials (Vol. 2, pp. 403-437). Elsevier Inc.. https://doi.org/10.1016/B978-1-78242-456-7.00020-9
Ousey, K. ; Roberts, C. D. ; Leaper, D. / Silver-containing dressings. Functional Biomaterials. Vol. 2 Elsevier Inc., 2016. pp. 403-437
@inbook{4273246d4c9e4ed9bbd21c9733023d0f,
title = "Silver-containing dressings",
abstract = "The use of silver as an antibacterial has been known for centuries, but its topical use in antimicrobial dressings to prevent or treat infection in a wide range of acute and chronic wounds is relatively new. Extensive laboratory and clinical evaluations have shown the antibacterial value of silver dressings, although efficacy may be dependent on the properties of a silver dressing, of which there are a wide range available. However, a randomised controlled trial and two Cochrane systematic reviews and meta-analyses have concluded that there is insufficient evidence to show that silver dressings improve healing rates. This conclusion is flawed as silver dressings never were meant to heal wounds, only to facilitate control of bioburden.Topical antiseptics, including silver, are well suited to control of bioburden and biofilm when used in conjunction with adequate debridement, and no relevant microbial resistance has been found. The rise of antibiotic-resistant organisms makes the reintroduction of a wider use of topical antiseptics an attractive alternative when antibiotic stewardship controls inappropriate antibiotic use.Few adequate randomised clinical trials have been undertaken, and supportive laboratory findings do need to be interpreted carefully into clinical practice. Nevertheless, silver dressings have a clear role in the management of bioburden and biofilm in open wounds.",
keywords = "Antiseptics, Bioburden, Biofilm, Burns, Chronic wounds, Infection, Silver dressings",
author = "K. Ousey and Roberts, {C. D.} and D. Leaper",
year = "2016",
month = "6",
day = "1",
doi = "10.1016/B978-1-78242-456-7.00020-9",
language = "English",
isbn = "9781782424567",
volume = "2",
pages = "403--437",
booktitle = "Functional Biomaterials",
publisher = "Elsevier Inc.",
address = "United States",

}

Ousey, K, Roberts, CD & Leaper, D 2016, Silver-containing dressings. in Functional Biomaterials. vol. 2, Elsevier Inc., pp. 403-437. https://doi.org/10.1016/B978-1-78242-456-7.00020-9

Silver-containing dressings. / Ousey, K.; Roberts, C. D.; Leaper, D.

Functional Biomaterials. Vol. 2 Elsevier Inc., 2016. p. 403-437.

Research output: Chapter in Book/Report/Conference proceedingChapter

TY - CHAP

T1 - Silver-containing dressings

AU - Ousey, K.

AU - Roberts, C. D.

AU - Leaper, D.

PY - 2016/6/1

Y1 - 2016/6/1

N2 - The use of silver as an antibacterial has been known for centuries, but its topical use in antimicrobial dressings to prevent or treat infection in a wide range of acute and chronic wounds is relatively new. Extensive laboratory and clinical evaluations have shown the antibacterial value of silver dressings, although efficacy may be dependent on the properties of a silver dressing, of which there are a wide range available. However, a randomised controlled trial and two Cochrane systematic reviews and meta-analyses have concluded that there is insufficient evidence to show that silver dressings improve healing rates. This conclusion is flawed as silver dressings never were meant to heal wounds, only to facilitate control of bioburden.Topical antiseptics, including silver, are well suited to control of bioburden and biofilm when used in conjunction with adequate debridement, and no relevant microbial resistance has been found. The rise of antibiotic-resistant organisms makes the reintroduction of a wider use of topical antiseptics an attractive alternative when antibiotic stewardship controls inappropriate antibiotic use.Few adequate randomised clinical trials have been undertaken, and supportive laboratory findings do need to be interpreted carefully into clinical practice. Nevertheless, silver dressings have a clear role in the management of bioburden and biofilm in open wounds.

AB - The use of silver as an antibacterial has been known for centuries, but its topical use in antimicrobial dressings to prevent or treat infection in a wide range of acute and chronic wounds is relatively new. Extensive laboratory and clinical evaluations have shown the antibacterial value of silver dressings, although efficacy may be dependent on the properties of a silver dressing, of which there are a wide range available. However, a randomised controlled trial and two Cochrane systematic reviews and meta-analyses have concluded that there is insufficient evidence to show that silver dressings improve healing rates. This conclusion is flawed as silver dressings never were meant to heal wounds, only to facilitate control of bioburden.Topical antiseptics, including silver, are well suited to control of bioburden and biofilm when used in conjunction with adequate debridement, and no relevant microbial resistance has been found. The rise of antibiotic-resistant organisms makes the reintroduction of a wider use of topical antiseptics an attractive alternative when antibiotic stewardship controls inappropriate antibiotic use.Few adequate randomised clinical trials have been undertaken, and supportive laboratory findings do need to be interpreted carefully into clinical practice. Nevertheless, silver dressings have a clear role in the management of bioburden and biofilm in open wounds.

KW - Antiseptics

KW - Bioburden

KW - Biofilm

KW - Burns

KW - Chronic wounds

KW - Infection

KW - Silver dressings

UR - http://www.scopus.com/inward/record.url?scp=85011769444&partnerID=8YFLogxK

U2 - 10.1016/B978-1-78242-456-7.00020-9

DO - 10.1016/B978-1-78242-456-7.00020-9

M3 - Chapter

SN - 9781782424567

VL - 2

SP - 403

EP - 437

BT - Functional Biomaterials

PB - Elsevier Inc.

ER -

Ousey K, Roberts CD, Leaper D. Silver-containing dressings. In Functional Biomaterials. Vol. 2. Elsevier Inc. 2016. p. 403-437 https://doi.org/10.1016/B978-1-78242-456-7.00020-9